ASIA QUARTZ
Asia Quartz · Advanced Materials

The technology is ready.

We only need to scale it.

Four proprietary ultra-materials — synthesized, characterized, and patent-protected. Heat-proof beyond 4000°C. Chemically inert. Quantum-stable. The only thing missing is your capital.

HeraeusAGH UniversityFILABINP KZKazNUNNC RKSumitomo ElectricToshibaHeraeusAGH UniversityFILABINP KZKazNUNNC RKSumitomo ElectricToshiba

Scientific & industrial partners

Status · 2026

What is already built.

Synthesized

Multi-stage recrystallization confirmed at lab scale with repeatable batch yields across all 4 material families.

Fully Characterized

XRF, XRD, SEM-EDS, IR spectroscopy, and BET surface analysis completed. Full data sets available.

Plasma-Tested >4000°C

ANEL and ALAN-M+ verified under argon plasma gun exposure. Zero structural degradation observed.

Chemically Inert

24h aqua regia immersion test completed. Mass loss < 0.01%. Morphology unchanged post-exposure.

Patent Protected

Registered Kazakhstan patent covering synthesis methods and composite structures. Click to view certificate.

Click to view →

10+ Partners Active

Heraeus, AGH, FILAB, INP KZ, NNC RK, Sumitomo, Toshiba — scientific and industrial validation network.

Portfolio · 4 Materials

Proprietary material families.

ADIL SEM
ADILStructural

SiO₂ · microcrystalline

Acicular microcrystals with 1:14 anisotropy ratio. Transforms isotropic matrices into directionally tuned load-bearing architectures. Hardness 7.5 Mohs, purity 98.5%.

Aerospace compositesDefense ballisticsAutomotive armor
ALEM SEM
ALEMQuantum-grade

SiO₂ · 99.97% ultra-pure

Silicon dioxide purified beyond semiconductor-grade specification. Quantum-stable lattice, Class I radiation resistance. Microelectronic tolerances measured in picometers.

Quantum computingSemiconductor fabSpace systems
ALAN-M+ SEM
ALAN-M+Bio-active

SiOₓ–C–Gas nanocomposite

Nanostructured SiOₓ–C composite with enclosed gas micropores. ROS-mediated tumor cell apoptosis confirmed in silico. Simultaneous ultrasound imaging via microcavitation nuclei (+15–20 dB signal).

Oncology therapeuticsUltrasound imagingNeuromodulation
ANEL SEM
ANELThermal Absolute

DLC · sp²–sp³ hybrid hexagonal

Diamond-like carbon with hexagonal sp²–sp³ hybrid lattice. Thermally stable beyond 4000°C. Electrically conductive. Inert to all reagents. 808nm NIR photothermal activator.

Fusion reactorsPlasma componentsPhotothermal therapy
Lab Evidence

Independently verified.
Physically tested.

XRF Elemental Analysis
XRF Elemental AnalysisSi/O ratio mapping, 20kV beamSiO₂ dominant phase confirmed, <0.5% impurities
SEM-EDS Morphology
SEM-EDS MorphologyFEI Quanta 450, 10kV accelerationAcicular needles 1:14 aspect ratio confirmed across samples
Plasma Gun Exposure
Plasma Gun ExposureArgon plasma, T > 4000°C, 10 minANEL: zero structural degradation, mass change < 0.02%
Aqua Regia Resistance
Aqua Regia ResistanceHNO₃:HCl 1:3, 24h exposureNo dissolution. Mass loss < 0.01%. Morphology unchanged
XRD Phase Analysis
XRD Phase AnalysisCu Kα radiation, 2θ = 10–80°Hexagonal sp²–sp³ hybrid structure confirmed for ANEL
BET Surface Analysis
BET Surface AnalysisN₂ adsorption at 77KMicropore distribution 0.5–5 µm verified in ALAN-M+
Methods Applied
XRF · Elemental composition
XRD · Phase structure
SEM-EDS · Morphology
IR spectroscopy
BET surface analysis
Plasma gun >4000°C
Aqua Regia immersion
Market · Opportunity

No direct competitors. Pricing power is absolute.

$0B+Total Addressable Market
$0K/gOsmium Reference Price
$0K+/kgANEL Current Value
$0M+/unitFusion Component
Total Addressable Market

Combined addressable markets across defense, energy, semiconductor, and medical sectors exceed $700B. Asia Quartz materials have no direct synthetic equivalents at the performance tier achieved.

Applications · Sectors

Where these materials deploy.

Defense & Aerospace

$200B+ TAM
  • ·Hypersonic vehicle shielding at >4000°C
  • ·Stealth + RF dual-mode materials (ALAN-M+)
  • ·Lightweight structural composites (ADIL)
  • ·Quantum-grade avionics substrates (ALEM)

Energy & Fusion

$150B+ TAM
  • ·Plasma-facing reactor components (ANEL)
  • ·Fusion chamber liner materials
  • ·High-temperature thermal management
  • ·Sensor housing beyond metallic limits

Medical Technology

$80B+ TAM
  • ·Tumor apoptosis induction (ALAN-M+)
  • ·Simultaneous ultrasound imaging
  • ·Neuromodulation via vagus nerve pathway
  • ·808nm photothermal therapy (ANEL+ALEM)

Semiconductor & Quantum

$270B+ TAM
  • ·Quantum-stable gate dielectrics (ALEM)
  • ·Ultra-pure process substrates (99.97% SiO₂)
  • ·Radiation-hardened packaging
  • ·Picometer-tolerance component fabrication
Roadmap · Timeline

The path to scale.

01
Discovery & Validation
2018–2024
  • Synthesis protocols developed for all 4 materials
  • Full laboratory characterization completed
  • Scientific partnerships established
  • Patent applications filed in Kazakhstan
02
Scale-Up & Strategic PartnershipsActive
2025–2026
  • Pilot batch production (100g → 1kg scale)
  • Industrial partner qualification programs
  • Heraeus & FILAB joint validation underway
  • Investor dossier released — Series A open
03
Industrial Deployment & Revenue
2027–2029
  • Commercial supply agreements with defense contractors
  • Medical device trial partnerships initiated
  • Fusion energy component supply chain entry
  • Target: $50M revenue run rate by 2029
Team · Founders

The science is personal.
The mission is industrial.

Rakhimberddinov A.O.
Rakhimberddinov A.O.Founder · Chief DeveloperFounder and strategic ideologist. Author of ALEM synthesis technology, selective PGM control via wave action, and investment proposals for the nuclear industry. Developed technical justifications for ALEM composites in fast-neutron and thermonuclear reactors.
Rakhadilov Baurzhan K.Scientific Partner · PhD, ProfessorDirector, PlasmaScience LLP (accred. #006242). Senior researcher, materials testing lab under thermonuclear reactor conditions, IAE NNC RK branch. Internships: JINR Dubna, Wrocław University of Science and Technology, Otto von Guericke University Magdeburg. 200 publications · 40 patents · h-index 14.
Investment · Partnership

Request the full dossier.

We respond within 48 hours.

01
Full Technical Dossier
Complete synthesis data, characterization results, and performance benchmarks in PDF format.
02
Financial Model
Revenue projections, cost-per-gram analysis, and market entry scenarios.
03
Partnership Terms
Licensing structures, co-development frameworks, and exclusivity options.
04
Direct Founder Contact
A scheduled call with the founding team within 5 business days of request.
Download PDF without form →

Request Investment Deck

Leave your contact — we respond within 48 hours with a full technical and commercial dossier.